To validate the expression of target genes BCL2 and PTEN in colon and prostate cancer, qPCR analysis was performed for both TQ-IC50-treated and untreated cells at 24 h, similar to the miRNA validation process. This evidence concerns the gene BCL2 and prostate cancer.